Earlier when FIIs were net sellers, they had their reasons for high Indian market valuations but now, that concern has been solved given the flat performance by the market and similarly FII buying is back given the valuation comfort coupled with better economics and fundamentals of Indian markets.
Max Health Q2 Results: Nifty’s latest entrant reports 74% YoY jump in cons PAT to Rs 491 crore, revenue grows 25%
Max Healthcare Institute has announced strong financial results for the September quarter. The company’s net profit surged by 74% year-on-year to Rs 491 crore. Revenue
